FDA Cites Yusef Labs for Inadequate Investigations, Quality Concerns

Drug Industry Daily
A A
The FDA put drugmaker Yusef Manufacturing Laboratories on notice over failures to address batch discrepancies and other quality issues.

To View This Article:

Login

Subscribe To Drug Industry Daily